Lung cancer screening boost for Affymetrix
This article was originally published in Clinica
Executive Summary
Affymetrix has boosted its efforts towards the development of a molecular screening test for lung cancer by teaming up with US researchers who have uncovered a less invasive way of acquiring test samples.